Sinovac Biotech, OverviewSinovac Biotech, Other Income Expense Net
Other Income/Expense Net for SVA.
Quarterly Other Income/Expense
$33.62M
↓ 81.04% YoY
As of Dec 31, 2023
Annual Other Income/Expense (TTM)
$887.43M
↑ 8795.7% YoY
Trailing 12 months ending Dec 31, 2023